ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
2.630
+0.040 (1.54%)
Dec 20, 2024, 4:00 PM EST - Market closed
ProQR Therapeutics Employees
ProQR Therapeutics had 157 employees as of December 31, 2023. The number of employees increased by 26 or 20.28% compared to the previous year.
Employees
157
Change (1Y)
26
Growth (1Y)
20.28%
Revenue / Employee
$130,947
Profits / Employee
-$170,511
Market Cap
271.43M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
Zynex | 1,100 |
OraSure Technologies | 638 |
Lifecore Biomedical | 524 |
Lexicon Pharmaceuticals | 285 |
COMPASS Pathways | 186 |
AC Immune | 161 |
C4 Therapeutics | 145 |
PRQR News
- 11 days ago - ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist - GlobeNewsWire
- 2 months ago - ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement - GlobeNewsWire
- 2 months ago - ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement - GlobeNewsWire
- 2 months ago - ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares - GlobeNewsWire
- 2 months ago - ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society - GlobeNewsWire
- 3 months ago - ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 8 months ago - ProQR Therapeutics N.V. (PRQR) ASGCT Investor Webcast (Transcript) - Seeking Alpha
- 8 months ago - ProQR Announces First Quarter 2024 Operating and Financial Results - GlobeNewsWire